Hollingsworth LLP Secures Summary Judgment for Northrop Grumman
Case | Environmental | February 25, 2025The Eastern District of New York agreed with Northrop Grumman that it was entitled to summary judgment on all of plaintiff’s claims.
Case
Hollingsworth LLP Wins 4th Circuit Appeal for Washington Commanders in Electronic Tickets Arbitration Matter
Case | Complex Litigation | October 29, 2024The case is Naimoli v. Pro-Football, Inc., No. 23-2020, —F.4th— (4th Cir. Oct. 29, 2024).
Hollingsworth LLP Secures a 12(b)(6) Dismissal for Horizon Therapeutics USA, Inc.
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | October 28, 2024The case is In Re: Tepezza Marketing, Sales Practices, and Products Liability Litigation, Case Number 1:23-cv-03568, U.S.D.C. N.D. Ill.
Hollingsworth LLP Obtains Partial Summary Judgment for Monsanto
Case | Products Liability & Toxic Torts | June 14, 2023The case is Whalen v. Monsanto in the Eastern District of Louisiana.
Hollingsworth LLP Secures Daubert Victory on Behalf of Bayer
Case | Products Liability & Toxic Torts | June 1, 2023N.D. Ca. excludes the opinions of plaintiff’s sole case-specific expert.
Firm Client Monsanto Takes Step Forward in 11th Circuit Preemption Appeal
Case | Products Liability & Toxic Torts | July 10, 2023In a lawsuit alleging that Monsanto’s Roundup-branded herbicides caused cancer, the en banc U.S. Court of Appeals for the Eleventh Circuit held that a three-judge panel of the court had incorrectly applied a “force of law”…
Firm Client Monsanto Secures Summary Judgment in Roundup Litigation
Case | Products Liability & Toxic Torts | September 29, 2021The U.S. District Court for the Middle District of Georgia granted summary judgment in favor of Firm client, Monsanto, on plaintiffs’ failure to warn and breach of implied warranty claims in a product liability lawsuit involving…
5th Circuit Affirms Novartis Summary Judgment in Tegretol Innovator Liability Case
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | February 5, 2021The court affirmed the Western District of Texas’s dismissal of plaintiff’s innovator liability claims under FRCP 12(b)(6).
Firm Secures Voluntary Dismissal with Prejudice for Novartis
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | June 29, 2020In a case involving terbutaline sulfate, the Firm secured a voluntary dismissal with prejudice for Firm client Novartis Pharmaceuticals Corporation. Pending in the U.S. District Court for the Southern District of Mississippi, plaintiff brought the case…
Idaho Court Dismisses Innovator Liability Claims Against Novartis for Lack of Specific Personal Jurisdiction
Case | Pharmaceutical & Medical Device | July 13, 2020The District Court of the Fourth Judicial District of the State of Idaho dismissed an innovator liability claim against Firm client Novartis Pharmaceuticals Corporation (“NPC”) for lack of specific personal jurisdiction. The court found that NPC’s…
Texas District Court Rejects Innovator Claims Against Novartis
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | May 7, 2020A Texas district court judge concluded that plaintiff failed to state a claim under Texas law for innovator liability-styled claims against Novartis Pharmaceuticals Corporation. On May 7, 2020, Chief Judge Orlando L. Garcia of the District…
Nuernberg v. Novartis Pharm. Corp., No. 01-0864-JJB-DLD (M.D. La. 2005)
Case | Pharmaceutical & Medical Device | November 14, 2005Novartis Successfully Defeats Punitive Damages Claim in Aredia/Zometa Litigation
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | July 10, 2014The U.S. District Court for the Southern District of Ohio held that federal law preempted punitive damages under both Ohio and New Jersey law in Monroe v. Novartis Pharm. Corp. Plaintiffs in Monroe filed their complaint…
Idaho State Court Rejects Innovator Liability Claims Against Novartis
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | September 25, 2019An Idaho state court judge concluded that plaintiffs failed to state a claim under Idaho law for innovator liability-styled claims against Novartis Pharmaceuticals Corporation. This is the first Idaho court to consider whether the state would…